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Summary 
The fluorescence of serotonin on binding with β-cyclodextrin has been studied using 
both steady-state and time-resolved methods. Steady state fluorescence intensity of 
serotonin at 340 nm showed ~ 30% increase in intensity on binding with Ka ~ 60 dm3 
mol-1 and the fluorescence lifetimes showed a corresponding increase. In contrast, the 
characteristic green fluorescence (‘hyperluminescence’) of serotonin observed upon 
multiphoton near-infrared excitation with sub-picosecond pulses was resolved into 
two lifetime components assigned to free and bound serotonin. The results are of 
interest in relation to selective imaging and detection of serotonin using the unusual 
hyperluminescence emission and in respect to recent determinations of serotonin by 
capillary electrophoresis in the presence of cyclodextrin. The results also suggest that 
hyperluminescence occurs from multiphoton excitation of a single isolated serotonin 
molecule. 
 
Keywords:- serotonin, cyclodextrin, fluorescence lifetime, multiphoton, 
hyperluminescence 
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Introduction 
 
Levels of the neurotransmitter serotonin have been linked to clinical depression and 
suicide.1 This has consequently created considerable interest in the development of 
analytical methods for determining serotonin levels in biological samples such as 
cerebrospinal fluid.2 A recent report describes the use of capillary electrophoresis in 
combination with hydroxypropyl-β-cyclodextrin for analyzing serotonin levels in 
brain microdialysis.3 The importance of neurotransmitters has also stimulated research 
to develop methods to locate them within living cells4 at physiological levels, in 
particular, and non-linear spectroscopic methods linked to microscopy have much 
potential in the field of neurobiology.5  The peak UV absorption of the  
5-hydroxyindole chromophore in both 5-hydroxytryptophan and serotonin occurs at a 
slightly longer wavelength than tryptophan. This has enabled the use of 
5-hydroxytryptophan as a fluorescence probe to study conformation and mobility 
within proteins.6  In RBL rat mast cells, confocal three-photon excitation using 
ultrafast near infrared laser pulses has enabled imaging of serotonin distribution and 
release by monitoring the UV fluorescence at 340 nm.7,8  We and others are presently 
exploring the further possibility for selective intracellular imaging of serotonin by 
taking advantage of the specific green emission (’hyperluminescence’) produced by 
multiphoton excitation of serotonin and 5-hydroxytryptophan.9,10 However, the 
identity of the molecular photoproduct responsible for hyperluminescence remains 
elusive. The supra-linear dependence of hyperluminescence intensity on serotonin 
concentration in phosphate buffer11 implies the possible involvement of a dimeric or 
higher aggregate photoproduct, although rapid capillary electrophoresis experiments 
indicate the photoproduct is of a similar size to serotonin itself.12 The present 
experiments, in which a molecule of serotonin is isolated within a cyclodextrin cavity, 
seek to resolve some aspects of this fundamental issue.   
 
Cyclodextrins, especially β-cyclodextrin (cycloheptaamylose), have found varied 
applications including drug solubilisation and delivery and in analytical chemistry 
procedures.13 This wide range of applications comes from their ability to form 
inclusion complexes and act as a host for various guest molecular species.  
Cyclodextrins possess a relatively hydrophobic cavity with the more polar hydroxyl 
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groups arranged around the external rim.   These features provide both isolation of the 
guest molecule from the surrounding environment as well as a means of improving 
aqueous solubility of hydrophobic compounds.  Cyclodextrins are able to modify the 
behaviour of electronically excited states of organic molecules,14 for example in 
permitting room temperature phosphorescence ,15 enhancement of fluorescence 
quantum yields16-19 and influencing the outcome of photochemical reactions.20 This 
present work has sought to further the earlier work using capillary electrophoresis in 
combination with hydroxypropyl-β-cyclodextrin 3 and quantify the nature of the 
serotonin:β-cyclodextrin complex and characterise the photophysical properties of 
both UV fluorescent and multiphoton hyperluminescence from serotonin.  
 
Experimental 
All chemicals including serotonin and β-cyclodextrin were purchased from Sigma-
Aldrich. Solutions were prepared in phosphate buffer (20 mmol dm-3, pH 7.0) 
containing NaCl (0.15 mol dm-3). 
 
Fluorescence spectra were measured using a Spex Fluoromax spectrofluorimeter 
using the manufacturer’s correction curve to obtain corrected spectra. Fluorescence 
lifetimes were measured using the time-correlated single photon counting technique 
using as the excitation source a Spectra-Physics Ti:Sapphire laser (120 fs pulses, 80 
MHz)  pumped by a 20 W argon ion laser (Spectra Physics Ltd). For one-photon 
excitation at 300 nm, the Ti:Sapphire laser output was shifted to 600 nm in a Mira 
OPO (Coherent) and doubled to 300 nm using a type 1 barium borate (BBO), 
delivering ~ 4mW to the sample. Fluorescence at 340 nm from a sample in a standard 
1 cm quartz cuvette was selected by a monochromator (M500, IBH) and detected with 
a Becker & Hickl GmbH photon-counting photomultiplier (Model PMH-100) linked 
to a Becker and Hickel SPC700 multichannel analyser card. Fluorescence decays 
were deconvoluted with the instrument response function using Edinburgh 
Instruments software. Multiphoton excitation at 750 nm used the direct output of the 
Ti:Sapphire laser (~60 mW at the sample). A drop of the sample on a cover slip was 
placed on the stage of a fluorescence microscope (Nikon TE2000) and green emission 
selected with a 505 nm interference filter (500IU25, Comar, UK).  Analysis of 
binding data by non-linear least squares analysis used the Grafit computer program. 
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Results and discussion 
Ultraviolet fluorescence 
Serotonin fluoresces in aqueous solution at pH 7 with a maximum at 334 nm on 
excitation at 300 nm.  Addition of β-cyclodextrin to solutions of serotonin (5 µmol 
dm-3) in solutions buffered with phosphate (20 mmol dm-3, pH 7.0) and NaCl (0.15 
mol dm-3) resulted in a small enhancement of the fluorescence intensity (Figure 1). 
Neither the excitation nor emission spectra showed any significant changes in shape 
or peak wavelengths with the addition of β-cyclodextrin.  This is consistent with the 
observation that the fluorescence properties of 5-hydroxyindole are relatively 
insensitive to solvent polarity.21 
  
The binding parameters for the serotonin (S) - β-cyclodextrin (β-CD) complex were 
evaluated on the basis of formation of a 1:1 complex as has previously been 
established in similar cases:-16,17 
 
                                         S + β-CD                  [S- β-CD]    ……. (1) 
 
The association constant of the complex, KA, was found by direct non-linear least 
squares fitting of plots of fluorescence intensity (F) versus β-cyclodextrin 
concentration according to the binding equation (2), where F0 is the intensity in the 
absence of β-cyclodextrin and Fmax is the maximal increase in intensity at infinite 
β-cyclodextrin concentration :- 
  
                                                                                             …….(2) 
 
Intensities were obtained by integration of the fluorescence spectra on excitation at 
300 nm and are shown plotted against β-cyclodextrin concentration in Figure 2. The 
best fit to equation (2) is shown by the line with KA = 53.2 ± 17.3 dm3 mol-1 and the 
value of Fmax corresponding to 33.8 ± 6.1% increase in fluorescence intensity of the 
fully complexed serotonin. (Note: The precision of the measurements of such a small 
KA for serotonin: β-cyclodextrin binding is limited by the solubility of β-cyclodextrin 
and the comparatively small change in fluorescence intensity observed).  It is 
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noteworthy that the value of KA for binding of serotonin by β-cyclodextrin obtained 
here is less than those for tryptamine17 and tryptophan16 (160 ± 30 and 184 ± 18 dm3 
mol-1 respectively) but the overall values for increases in fluorescence intensity on 
binding are similar.  
 
Time-resolved fluorescence decays of serotonin, excited at 300 nm and detected at 
340 nm, were measured using the time-correlated single photon counting technique. 
In the absence of cyclodextrin, the fluorescence decay was satisfactorily deconvoluted 
(χ2 < 1.2) as a single exponential with a lifetime of 3.65 ns, in good agreement with a 
previous determination of 3.80 ns at pH 7.22 Addition of β-cyclodextrin resulted in an 
increase in fluorescence lifetime (Figure 4), reaching a value of 4.24 ns in the 
presence of 20 mmol dm-3 β-cyclodextrin. The increase in fluorescence lifetime 
(16%) closely matches the rise of steady state fluorescence intensity (18%) at 20 
mmol dm-3 β-cyclodextrin recorded above. 
 
 
Time-resolved hyperluminescence 
Multiphoton excitation of serotonin using an ultrafast near-infrared laser is known to 
produce the green fluorescence at 505 nm (‘hyperluminescence’).  This corresponds 
to a 6-photon process, involving the initial formation of photochemical intermediate 
in a four-photon step, followed by excitation of the intermediate by a further two 
photons.9  For this work we used a focussed laser beam (750 nm, 130 fs pulses, 80 
MHz, 56 mW at the sample) produced by a Ti:sapphire laser. The decay of 
hyperluminescence from solutions of serotonin (1 mmol dm-3, pH 7.0) was 
biexponential.  Due to the inherently weaker emission in the hyperluminescence 
experiments, a higher serotonin concentration (1 mmol dm-3) was used. However over 
most of the range of cyclodextrin concentrations used (2.5 to 20 mmol dm-3), the 
cyclodextrin is present in modest excess (≥ 5:1 molar ratio) and analysis of data using 
equation (2) is justified. Representative time-resolved decays are shown in Figure 3 
and analysis shows they contain a short lifetime (τ1) of 710 ± 17 ps that is found to be 
independent of cyclodextrin concentration. However, the lifetime of a second 
component (τ2) increased from 1.65 ns in the absence of β-cyclodextrin to a limiting 
value of 3.4 ± 0.3 ns above β-cyclodextrin concentrations of 10 mmol dm-3 (Figure 4). 
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More complex analysis of the data was not attempted and the increase in the long 
lifetime component to this limiting value is taken to indicate the eventual 
predominance of the longer lifetime component due to serotonin to β-cyclodextrin. 
The fractional intensity of the longer lifetime component (f2), defined by equation 3 
where α1 and α2 are the pre-exponential factors from the fitting analysis,  
 
increased with increasing β-cyclodextrin concentration (Figure 5). The variations of 
the fractional intensities of the two lifetime components versus β-cyclodextrin 
concentration are shown in Figure 5 with the solid lines representing best fits to the 
equivalent of equation (2) with KA =  59.4 ± 11.2 and 53.8 ± 10.6 dm3 mol-1 for the 
short and long component intensities respectively. These values are consistent with 
the binding constant (53.2 ± 17.3 dm3 mol-1) obtained from the steady state 
fluorescence experiments described above.  Extrapolation of the data shows that at 
saturating β-cyclodextrin concentrations only emission from bound serotonin is 
observed with the percentage intensity of the lifetime for the bound form of 120 ± 
11% and that for the free form of 15 ± 10%. 
 
As similarly reported in a study of fluorescence lifetimes measured on the binding 
2-amino-5,6-dimethylbenzimidazole to β-cyclodextrin,19 the hyperluminescence 
decays from serotonin clearly contain exponential components attributable to bound 
and free species. For the hyperluminescence the principal lifetimes of bound and free 
serotonin are 3.4 ns and 0.71 ns respectively. It might have been anticipated that 
differentiation of bound and free serotonin would be observed in the single photon-
excited ultraviolet (340 nm) fluorescence decays from serotonin. However since both 
intensity and lifetimes show equivalent small increases of only 16-18% over the 
available β-cyclodextrin concentration range, the two lifetimes may not have been 
identified within the deconvolution process. Hyperluminescence from 
5-hydroxytryptophan has been shown to have a similarly short lifetime in aqueous 
solution of 0.91 ns.10 Unlike the fluorescence lifetime of the normal ultraviolet (340 
nm) fluorescence of 5-hydroxytryptophan,21 hyperluminescence lifetimes were found 
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to be very responsive to solvent,10 increasing up to 3.1 ns in 90% ethanol in water, a 
value rather similar to the lifetime identified here with the hyperluminescent species 
bound within the β-cyclodextrin cavity.  
 
Hyperluminescence of molecules such as serotonin and 5-hydroxytryptophan offers 
new opportunities in the detection11 and imaging23 of these compounds. The transient 
species responsible for hyperluminescence remains unidentified, although new routes 
to multiphoton excitation of serotonin have been explored recently.24 Capillary 
electrophoresis experiments have been used to eliminate dimer or higher multimers of 
serotonin as being responsible for the intermediate that produces the 
hyperluminescence.12  In biological systems there is the possibility that serotonin may 
be bound to proteins such as albumin, and that binding may affect attempts to 
quantify or image serotonin using hyperluminescence. The results show that whilst 
native ultraviolet fluorescence may be relatively unaffected by binding, the 
hyperluminescence lifetime is more sensitive and might be used as an indicator of 
such interactions. 
 
In the present experiments there are two possibilities leading to hyperluminescence 
from serotonin with the lifetime of 3.4 ns.  This value is characteristic of the 
fluorophore being located within an environment with a polarity lower than water. 
Thus the first possibility is the photochemical conversion of serotonin to the 
hyperluminescent intermediate arises from the 4-photon excitation (at 750 – 830 nm) 
of a serotonin molecule already complexed within the β-cyclodextrin cavity.  This 
intermediate whilst still complexed may then be further excited by a further two 
photons to generate the hyperluminescence.  In this case the hyperluminescence 
comes from an isolated single serotonin molecule.  An alternative mechanism for the 
hyperluminescence with 3.4 ns lifetime is that the initial intermediate is formed by the 
four-photon process in solution. This may then associate with cyclodextrin during its 
lifetime (>100 microseconds)9 before being excited to give hyperluminescence from 
within the cyclodextrin cavity. In the latter case the similarity of the association 
constants in the static fluorescence observed at 340 nm generated by UV excitation 
and the time-resolved hyperluminescence experiments indicate similar sizes and 
polarities of the serotonin molecule and the intermediate species. These arguments 
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support the hypothesis that hyperluminescence occurs from a monomer species 
derived from serotonin, and that it should be possible to observe hyperluminescence 
from a single residue of 5-hydroxytryptophan within a protein. 
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Figure legends 
 
FIGURE 1  Fluorescence spectra from serotonin (5 µmol dm-3) excited at 300 nm in 
solutions at pH 7 containing:- 0 (curve 1); 5 (curve 2); 10 (curve 3) and 
20 (curve 4) mmol dm-3 β-cyclodextrin. 
 
 
FIGURE 2   Increase in fluorescence intensity from solutions of serotonin (5 µmol 
dm-3) at pH 7 on addition of β-cyclodextrin. The solid line indicates the 
fit with Ka= 53.2 dm3 mol-1, as described in the text. 
 
 
FIGURE 3   Nanosecond time-resolved fluorescence decays at 505 nm following 
multiphoton excitation at 750 nm of serotonin (1 mmol dm-3) in 
solutions (pH 7) containing β-cyclodextrin:- none (trace 1); 5 mmol dm-3 
(trace 2); 10 mmol dm-3 (trace 3) and 20 mmol dm-3 (trace 4). 
 
 
FIGURE 4   Fluorescence (hyperluminescence) lifetimes of the biexponential decay 
from serotonin (1 mmol dm-3) on multiphoton excitation at 750 nm and 
pH 7 with increasing β-cyclodextrin concentration. Emission was 
observed at 505 nm. Increasing the β-cyclodextrin concentration had no 
effect on the short lifetime component (■), whilst the lifetime of longer 
component increased (□). Also shown are the single exponential 
lifetimes of the UV fluorescence at 340 nm, excited at 300 nm (▲). 
 
FIGURE 5   Intensity contributions in the biexponential decay of serotonin 
fluorescence (hyperluminescence) at 505 nm after multiphoton 
excitation at 750 nm with increasing β-cyclodextrin concentration. 
Relative intensity (percentage) contributions are shown for the short 
lifetime component (□) and the long lifetime component (■). 
 
 
 
 
 
 
 
 
 12 
 
 
 
 
 
0
10
20
30
40
50
60
70
80
300 325 350 375 400 425
spectrum 4   
spectrum 1
Fl
uo
re
sc
en
ce
 R
el
at
iv
e 
In
te
ns
ity
Wavelength (nm)
Fl
uo
re
sc
en
ce
 R
el
at
iv
e 
In
te
ns
ity
Fl
uo
re
sc
en
ce
 R
el
at
iv
e 
In
te
ns
ity
 
 
FIGURE 1 
 
 
95
100
105
110
115
120
0 5 10 15 20 25
[β-Cyclodextrin] mmol dm-3
R
el
at
iv
e 
Fl
uo
re
sc
en
ce
 In
te
ns
ity
 FIGURE 2 
 13 
[β-cyclodextrin] mmol dm-3
Fl
uo
re
sc
en
ce
 li
fe
tim
e 
(p
s)
0
500
1000
1500
2000
2500
3000
3500
4000
4500
0 5 10 15 20
Fl
uo
re
sc
en
ce
 li
fe
tim
e 
(p
s)
FIGURE 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2 
FIGURE 3 
1
10
100
1000
0 2 4 6 8
Time (ns)
C
ou
nt
s
decay 4
decay 1
C
ou
nt
s
C
ou
nt
s
 14 
20
30
40
50
60
70
80
0 5 10 15 20
[β-cyclodextrin] mmol dm-3
Fr
ac
tio
na
l I
nt
en
sit
y 
(%
)
FIGURE 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
